Showing results (101-110 of 174) with videos related to

Sort By:
Pageof 18
AIDS (London, England)|July 19, 2014
Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patientsKarin J Metzner, Alexandra U Scherrer, Viktor von Wyl, et al.
Plos One|October 25, 2014
Generation of a recombinant Gag virus-like-particle panel for the evaluation of p24 antigen detection by diagnostic HIV testsBeatrice N Vetter, Vanessa Orlowski, Katrien Fransen, et al.
The Journal of Antimicrobial Chemotherapy|September 13, 2015
Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort StudyWan-Lin Yang, Roger D Kouyos, Alexandra U Scherrer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 29, 2012
Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluidAlexia Cusini, Pietro L Vernazza, Sabine Yerly, et al.
Elife|June 1, 2021
Systematic screening of viral and human genetic variation identifies antiretroviral resistance and immune escape linkHuyen Nguyen, Christian Wandell Thorball, Jacques Fellay, et al.
The Journal of Antimicrobial Chemotherapy|February 14, 2013
Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide studyLambert Assoumou, Diane Descamps, Sabine Yerly, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 10, 2021
Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillanceJavier Perez-Saez, María-Eugenia Zaballa, Sabine Yerly, et al.
Scientific Reports|June 15, 2016
Genotypic Resistance Tests Sequences Reveal the Role of Marginalized Populations in HIV-1 Transmission in SwitzerlandMohaned Shilaih, Alex Marzel, Wan Lin Yang, et al.
Swiss Medical Weekly|May 16, 2024
Costs and acceptability of simplified monitoring in HIV-suppressed patients switching to dual therapy: the SIMPL'HIV open-label, factorial randomised controlled trialAnnalisa Marinosci, Delphine Sculier, Gilles Wandeler, et al.
Journal of Clinical Medicine|April 30, 2021
Head-to-Head Evaluation of Five Automated SARS-CoV-2 Serology Immunoassays in Various Prevalence SettingsDiego O Andrey, Sabine Yerly, Benjamin Meyer, et al.
Pageof 18